Source: MORNING AG CLIPS, 4/29/18

Mastitis is the most expensive disease in the dairy industry. Each clinical case can cost a dairy farmer more than $400 and damages both the cow’s future output as well as her comfort. Bovine mastitis is typically treated with antibiotics, but with the potential threat of antimicrobial resistance and the disease’s long-term harm to the animal’s teat, researchers at the Cornell University College of Veterinary Medicine are laying the foundation for alternative therapies derived from stem cells.

For more of this story, click here.